The majority of panelists (59%) preferred fresh strawberries that tasted more sweet than tart and another 36% preferred them at least equally sweet and tart.
The effect of IBA on tactile sensitivity was assessed using ANOVA and a binomial analysis was used to determine whether a significant majority of panelists were able to detect the stimuli under each treatment condition.
In the 2013 St Gallen Consensus Conference, the majority of panelists voted Ki-67 for taking into account regarding the application of adjuvant chemotherapy in individual cases [ 16].
We defined a consensus on the importance of teaching a topic as receiving a score of 4 (very important) or 5 (essential) from a simple majority of panelists.
The issue of replacing CT by MRI scan was one area of controversy, but considered as not feasible in the majority of European countries by the majority of panelists.
In PET CT positive patients after chemotherapy either biopsy, close observation with serial CT scans or, possibly, repeat PET CT scans were recommended by the majority of panelists (supplementary material S16, available at Annals of Oncology online).
The majority of panelists voted against performing biopsies in EGCC patients when both of the testes were normal upon clinical examination and ultrasound (supplementary material S3, available at Annals of Oncology online).
In the even more unfavorable patients relapsing with brain metastases, the majority of panelists voted for full salvage chemotherapy, but again no consensus could be achieved in respect to additional treatments (supplementary material S33, available at Annals of Oncology online).
As the benefit of CIS/TIN detection and the possibility of assessing spermatogenesis, fertility is counterbalanced by infertility in 100% and in hypogonadism in ∼30% of patients after radiotherapy with the subsequent need for testosterone supplementation, the majority of panelists opted against routine biopsies to detect CIS/TIN.
The majority of panelists opted to start pre-phase induction chemotherapy either with carboplatin alone or with the combination of carboplatin and etoposide and continue with four cycles of full-dose BEP or VIP from on day 11 onwards when the patients have stabilized and recovered with their renal function (supplementary material S30, available at Annals of Oncology online).
